PET in Breast Cancer Receiving Neoadjuvant Chemotherapy
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Prognostic factors in locally advanced breast cancer treated with neoadjuvant chemotherapy
differ from those of early breast cancer.
The purpose of this study was to identify the clinical significance of potential predictive
and prognostic factors including serial FDG PET/CT in breast cancer patients treated by
neoadjuvant chemotherapy.